Cargando…

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients

OBJECTIVE: Clinical trials to date have not provided definitive evidence regarding the effects of glucose lowering with coronary heart disease (CHD) risk among diabetic patients. RESEARCH DESIGN AND METHODS: We prospectively investigated the association of HbA(1c) at baseline and during follow-up wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wenhui, Katzmarzyk, Peter T., Horswell, Ronald, Wang, Yujie, Johnson, Jolene, Hu, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179505/ https://www.ncbi.nlm.nih.gov/pubmed/24130365 http://dx.doi.org/10.2337/dc13-1525

Ejemplares similares

BMI and Coronary Heart Disease Risk Among Low-Income and Underinsured Diabetic Patients
por: Li, Nan, et al.
Publicado: (2014)

HbA(1c) and Lower-Extremity Amputation Risk in Low-Income Patients With Diabetes
por: Zhao, Wenhui, et al.
Publicado: (2013)

HDL Cholesterol and Cancer Risk Among Patients With Type 2 Diabetes
por: Zhao, Wenhui, et al.
Publicado: (2014)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
por: Tan, Xiao, et al.
Publicado: (2020)

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

HbA(1c) as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial
Publicado: (2015)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Undiagnosed diabetes based on HbA(1c) by socioeconomic status and healthcare consumption in the Tromsø Study 1994–2016
por: Ruiz, Paz Lopez-Doriga, et al.
Publicado: (2021)

The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
por: Tang, Mengyao, et al.
Publicado: (2023)

Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c
por: Mühlenbruch, Kristin, et al.
Publicado: (2018)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

Aggressive Blood Pressure Control Increases Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2013)

Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark
por: Nicolaisen, Sia K, et al.
Publicado: (2022)

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA
por: Pagán, Lorissa, et al.
Publicado: (2023)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies
por: Furukawa, Takuma, et al.
Publicado: (2022)

Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study
por: Hodel, Nikolai Carl, et al.
Publicado: (2020)

Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Basit, Abdul, et al.
Publicado: (2020)

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
por: Lu, Yunxia, et al.
Publicado: (2015)

Associations between adolescent experiences, parent experiences and HbA1c: results following two surveys based on the Norwegian Childhood Diabetes Registry (NCDR)
por: Iversen, Hilde Hestad, et al.
Publicado: (2019)

Assessing widening disparities in HbA1c and systolic blood pressure retesting during the COVID-19 pandemic in an LGBTQ+-focused federally qualified health center in Chicago: a retrospective cohort study using electronic health records
por: Rivera, Adovich S, et al.
Publicado: (2022)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)

IDF2022-0948 Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a ‘Nearly Post COVID-19’ World
por: Fryer, A., et al.
Publicado: (2023)

Patient-specific factors associated with use of diabetes self-management education and support programs in Louisiana
por: Yoshida, Yilin, et al.
Publicado: (2021)

Hemoglobin A(1c) and the Progression of Coronary Artery Calcification Among Adults Without Diabetes
por: Carson, April P., et al.
Publicado: (2015)

Oral diabetes medication monotherapy and short-term mortality in individuals with type 2 diabetes and coronary artery disease
por: Raghavan, Sridharan, et al.
Publicado: (2018)

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study
por: Lee, Jennifer S., et al.
Publicado: (2017)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016
por: Langholz, Petja Lyn, et al.
Publicado: (2021)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study
por: Effoe, Valery S., et al.
Publicado: (2015)

Level of education is associated with coronary heart disease and chronic kidney disease in individuals with type 2 diabetes: a population-based study
por: Slåtsve, Kristina B, et al.
Publicado: (2022)

Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes
por: Blecker, Saul, et al.
Publicado: (2016)

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

Longitudinal HbA(1c) trajectory modelling reveals the association of HbA(1c) and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus
por: Tee, Clarence, et al.
Publicado: (2023)

Case report: Effect of Hb E heterozygosity on HbA1c value by the Tosoh HLC-723G11
por: Gao, Wei, et al.
Publicado: (2023)

Trends in Diabetes Incidence: The Framingham Heart Study
por: Abraham, Tobin M., et al.
Publicado: (2015)

Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT
por: Varvel, Stephen A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5u72h38b9l6fuq7kvn7fse7e1d